Capital World Investors Moderna, Inc. Transaction History

Capital World Investors

$625 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $1.93 Million - $3.17 Million	19,054 Added 0.52%	3,667,171 $435 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $1.6 Million - $2.16 Million	18,728 Added 0.52%	3,648,117 $389 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $23.5 Million - $35.3 Million	-338,342 Reduced 8.53%	3,629,389 $361 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $2.59 Million - $3.4 Million	26,859 Added 0.68%	3,967,731 $410 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $2.52 Million - $3.42 Million	21,282 Added 0.54%	3,940,872 $479 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $2.24 Million - $3.26 Million	16,525 Added 0.42%	3,919,590 $602 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $237 Million - $421 Million	2,002,125 Added 105.32%	3,903,065 $701 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $831,330 - $1.37 Million	7,041 Added 0.37%	1,900,940 $225 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $1.11 Million - $1.68 Million	9,504 Added 0.5%	1,893,899 $271 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $13.1 Million - $24.3 Million	-103,594 Reduced 5.21%	1,884,395 $325 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $140,460 - $229,213	-622 Reduced 0.03%	1,987,989 $505 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $3,106 - $6,782	14 Added 0.0%	1,988,611 $765 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $22.4 Million - $40.4 Million	172,115 Added 9.48%	1,988,597 $467 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $198 Million - $338 Million	1,816,482 New	1,816,482 $238 Million

Others Institutions Holding MRNA

# of Institutions

940

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account